Objective: To investigate the effects of tripterygium wilfordii polyglycoside tablets combined with NB-UVB on inflammation level, blood lipid indexes and stroke risk in patients with psoriasis vulgaris. Methods: 72 patients with psoriasis vulgaris treated in our hospital from January 2020 to December 2021 were selected. According to the random number table method, 72 patients were divided into thematched group (n = 36) and observation group (n = 36). The matched group were treated with NB-UVB total body irradiation, while patients in observation group were treated with tripterygium wiltergium polyglycoside tablets on the basis of matched group. The treatment effect of the two groups was compared, the PASI score of the two groups before treatment and after treatment for 12weeks were compared, the serum levels of IL-22, IL-17, TNF-α and YKL-40 of the two groups before treatment and after treatment for12 weeks were compared, and the serum lipid levels of the two groups before treatment and after treatment for 12 weeks were compared. The degree of stroke risk at 12 weeks of treatment were compared between the two groups, and the incidence of adverse reactions during treatment were compared between the two groups. Results: The effectiveness of observation group 98.33% was higher than matched group 86.67% (P<0.05). Before treatment, there was no difference in PASI score between the two groups (P>0.05). After treatment for 12weeks, the PASI score of the two groups decreased, and the observation group was lower than the matched group (P<0.05). Before treatment, there was no difference in serum levels of IL-22, IL-17, TNF-α and YKL-40 between the two groups. After treatment for 12weeks, the serum levels of IL-22, IL-17, TNF-α and YKL-40 in the two groups were decreased, and the observation group was lower than the matched group (P<0.05). Before treatment, there was no difference in serum lipid levels between the two groups (P>0.05). After treatment for 12 weeks, the levels of total cholesterol, triglyceride and low-density lipoprotein in the observation group were decreased, while the levels of high-density lipoprotein were significantly increased, and the comparison between the observation group and the matched group was significant (P<0.05), while the comparison between the matched group and before treatment was not significant (P>0.05). After treatment for 12 weeks, the risk of stroke in the observation group was lower than matched group (P<0.05). During the treatment, both groups of patients completed the treatment without obvious adverse reactions. Conclusion: Compared with NB-UVB alone, tripterygium wilfordii polyglycoside tablets combined with NB-UVB can reduce the level of inflammation, improve the level of blood lipid, and reduce the risk of stroke in patients with psoriasis vulgaris. [ABSTRACT FROM AUTHOR]